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Cell cycleT-type Ca2+ channels (TTCCs) are expressed in the fetal heart and then disappear from ventricular myocytes
after birth. The hypothesis examined in this study was the α1G TTCCs' inﬂuence in myocyte maturation and
their rapid withdrawal from the cell cycle after birth.
Methods: Cardiac myocytes were isolated from neonatal and adult wild type (WT), α1G−/− and α1G over
expressing (α1GDT) mice. Bromodeoxyuridine (BrdU) uptake, myocyte nucleation, cell cycle analysis, and
T-type Ca2+ currents were measured.
Results: All myocytes were mono-nucleated at birth and 35% of WT myocytes expressed functional TTCCs.
Very few neonatal myocytes had functional TTCCs in α1G−/− hearts. By the end of the ﬁrst week after
birth no WT or α1G−/− had functional TTCCs. During the ﬁrst week after birth about 25% of WT myocytes
were BrdU+ and became bi-nucleated. Signiﬁcantly fewer α1G−/− myocytes became bi-nucleated and
fewer of these myocytes were BrdU+. Neonatal α1G−/− myocytes were also smaller than WT. Adult
WT and α1G−/− hearts were similar in size, but α1G−/− myocytes were smaller and a greater % were
mono-nucleated. α1G over expressing hearts were smaller than WT but their myocytes were larger.
Conclusions: The studies performed show that loss of functional TTCCs is associated with bi-nucleation and
myocyte withdrawal from the cell cycle. Loss of α1G TTCCs slowed the transition from mono- to bi-nucleation
and resulted in an adult heart with a greater number of small cardiac myocytes. These results suggest that
TTCCs are involved in the regulation of myocyte size and the exit of myocytes from the cell cycle during the
ﬁrst week after birth.
© 2013 The Authors. Published by Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
T-type Ca2+ channels (TTCCs) are expressed in the fetal heart
during development [1–3], but their expression deceases after birth
[4–6]. These channels are not present in the ventricle of most normal
adult animals but are re-expressed in cardiac disease states and are
associated with cardiac hypertrophy [7]. While the biophysical prop-
erties of TTCCs are well described [2,8], their biological functions are
not well known. In the heart there is evidence that TTCCs are involved
in the generation of pacemaker potentials [9], but do not appear
to play any substantial role in excitation–contraction coupling [2,8].
In smooth muscle and in cancers there is a linkage between the+1 215 707 4003.
td. Open access under CC BY-NC-ND lipresence of TTCCs and cellular proliferation [10–12], suggesting that
Ca2+ inﬂux through TTCCs inﬂuences the cell cycle.
Cardiac myocytes are proliferative in the fetal heart but soon after
birth ventricular myocytes become terminally differentiated and bi-
nucleated and lose their ability to reenter the cell cycle [13–15].
There is an association between fetal myocyte proliferation and the
presence of TTCCs and the reduced expression of TTCCs after birth is
associated with the exit of ventricular myocytes from the cell cycle.
The working hypothesis of this study is that α1G TTCCs are in-
volved in the regulation of myocyte size and cell cycle after birth.
The objectives of the present study were (1) to deﬁne the relationship
between the reduction of TTCC expression in normal cardiac myocytes
after birth and their exit from the cell cycle in the ﬁrst week after birth,
and (2) to determine the effects of loss of α1G TTCCs (α1G−/−) on
myocyte size, proliferation, binucleation and the exit of myocytes from
the cell cycle after birth.
The experiments performed in the present study showed that
TTCC currents are observed in about 35% of ventricular myocytes
immediately after birth in normal hearts but almost no myocytescense.
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α1G TTCCs in the normal, wild type mouse heart was associated
with an increase in the percentage of binucleatedmyocytes and an in-
crease in myocyte size. In α1G−/− mice there were very few (b5%)
myocytes with any TTCC current at birth and no myocytes with TTCCs
were found in seven day old animals. There was also a slower develop-
ment of myocyte binucleation after birth and myocyte size was smaller
inα1G−/−neonatalmice. In the adultα1G−/−mouse, heart sizewas
normal, but myocyte size was smaller than in normal animals andmore
adult α1G−/− myocytes were mononucleated. These ﬁnding suggest
that the loss of α1G TTCCs slowed the exit of adult cardiac myocytes
from the cell cycle, leading to an adult heart with an increased number
of smaller, mononucleated cardiac myocytes. Collectively these studies
suggest that Ca2+ inﬂux through α1G TTCCs regulates the exit of
cardiac myocytes from the cell cycle and their growth during the
ﬁrst week after birth.
2. Material and methods
2.1. Mice
Wild type C57BL/6 mice were obtained from Jackson Laboratories.
α1G gene-targeted knockout mice (α1G−/−) were provided by
Dr. Jeffrey Molkentin [16]. Cardiac-speciﬁc α1G subunit over-expressing
transgenic mice (α1G double transgenic, DT) were generated by
using a modiﬁed murine α-myosin heavy chain (α-MHC) promoter
expression vector as described previously [17,18]. In the absence of
tetracycline/doxycycline (Dox), responder transgene α1G TTCC ex-
pression is permitted in the presence of tetracycline transactivator
(tTA) protein. Heterozygous tTa and α1G breeding pairs produced
α1GDT mice that were deprived of Dox food after birth to activate
gene expression [19,20]. The experiments followed guidelines pro-
vided by the National Institutes of Health Guide for the Care and
Use of Laboratory Animals. All procedures were approved by the
Institutional Animal Care and Use of Committee at Temple University
School of Medicine.
2.2. Neonatal mouse cardiomyocyte isolation and culturing
Neonatal cardiomyocytes were prepared from pups on days 1 or 7
after birth. Neonatal mice were decapitated, the chest cavities were cut
open and themouseheartswere removed. Subsequently, cardiomyocytes
were dispersed by incubation with DNase (0.2 mg/ml) and trypsin
(3 mg/ml) buffer solution containing the following in mM: NaCl 137,
KCl 5.36,MgSO4-7H2O 0.81, dextrose 5.55, KH2PO4 0.44, Na2HPO4-7H2O
0.34, and HEPES 20, pH 7.5, and the cellular suspension was ﬁltered
through a polypropylene macroporous ﬁlter (mesh opening: 100 μm).
The suspension was then centrifuged at 1000 rpm for 5 min, the cellu-
lar pellet was suspended inMEMwith Hank's balanced solution (Gibco,
Cat# 11575-032) with 5% FBS and penicillin–streptomycin (50 μg/ml).
Cellular suspensions were used in ﬂow cytometry experiments. For
cell cycle studies the cell suspension was preplated at 37 °C for 1 h in
1% CO2 to reduce non-myocyte contamination. 2 × 105myocytes were
then plated in polystyrene, nonpyrogenic 12-well culture plates which
had been coated with 1% gelatin at room temperature for 2 h. Neonatal
myocytes were incubated in 1% CO2 at 37 °C for 24 h before immuno-
ﬂuorescence or electrophysiology studies.
2.3. Adult cardiomyocyte Isolation and culture
Mice were anesthetized with sodium pentobarbital (0.5 mg/100 g,
i.p.). Hearts were perfused via the aorta with Tyrode solution
[composition in mM: glucose 10, HEPES 5, CaCl2 0.02, KCl 5.4, NaCl
150, MgCl2 1.2, and sodium pyruvate 2, pH 7.4] containing collagenase
(300 U/ml). After 6–7 min of perfusion the heart softened and the
ventricles were minced and ﬁltered through macroporous ﬁlter (meshopening: 100 μm). Isolated ventricular myocytes were equilibrated in
Tyrode solution [composition in mM: glucose 10, HEPES 5, CaCl2 1.0,
KCl 5.4, NaCl 150, MgCl2 1.2, and sodium pyruvate 2, pH 7.4] and 0.5%
bovine serum albumin. Myocytes were seeded (4 × 104) in polysty-
rene, nonpyrogenic 12-well culture plates precoated with 40 μg/ml
laminin.
2.4. Immunohistochemistry
Newly formed DNA was identiﬁed by BrdU (Roche) incorporation
into the DNA of cardiomyocytes which were isolated from both wild
type (WT) and α1G−/− mice. For BrdU incorporation experiments,
neonatal mice were injected with 1 mg BrdU per 6 g body weight
(IP). BrdU injection was performed twice a day for 7 days. On day 7,
neonatal mice were decapitated, the chest cavities were cut open
and the mouse hearts were removed. Hearts were ﬁxed in formalin.
Using standard procedures, tissue sections (5 μm) were incubated
with BrdU antibodies (target for cell proliferation), cardiac α-actin
antibodies and DAPI (to identify nuclei). BrdU+ myocyte nuclei
were identiﬁed as we have described previously [21].
2.5. Myocyte cross-sectional area
Hearts were perfusion ﬁxed with 10% formalin [2], embedded
in parafﬁn and 5 μm thick sections were cut and stained with
hematoxylin/eosin [22]. Cardiomyocyte cross-sectional area was
measured from areas that were clearly cut in cross section. Images
were analyzed using NIH Image J software system.
Isolated adult ventricular cardiomyocytes were cultured on cover
slips at room temperature for 1.5 h, then ﬁxed in 4% paraformalde-
hyde solution at room temperature for 10 min and permeabilized in
0.25% Triton X-100 immediately before labeling with antibodies.
Staining of cardiac α-actinin and DAPI was performed to detect
myocytes and nuclei. Cardiomyocytes were cultured and ﬁxed on 4
cover slips mounted onto slides and 12 random ﬁelds from each
cover slip were observed with a confocal microscope (Nikon). Images
were analyzed with EZ-C1 FreeViewer (Nikon) and ImageJ (NIH) soft-
ware. Comparison was made between the two groups WT (n = 3; n:
number of mice) and α1G−/− (n = 3).
Isolated neonatal ventricular cardiomyocyteswere cultured at 37 °C
and 1% CO2 for 48 h, then ﬁxed in 4% paraformaldehyde solution and
permeabilized in 0.05% Triton X-100 immediately before labeling with
antibodies directed against α-actinin. Staining of α-actinin and DAPI
was performed to detect myocytes and their nuclei respectively.
Cardiomyocytes were cultured and ﬁxed on 4 cover slips, cover slips
were mounted onto slides and 10 random ﬁelds for each cover slip
were observed. Images were analyzed with EZ-C1 FreeViewer (Nikon)
and ImageJ (NIH) software. Comparison was made between the two
groups WT (n = 10 on day 1, n = 10 on day 7; n: number of neonatal
mice) and α1G−/− (n = 8 on day 1, n = 9 on day 7).
2.6. Flow cytometry
Flow cytometry was performed on myocytes from neonatal mouse
hearts: neonatal mouse hearts were isolated under a dissecting micro-
scope, gently minced and then dissociated to single cell solution with
DNase (0.2 mg/ml) and trypsin (3 mg/ml) buffer solution [composition
in mM: NaCl 137, KCl 5.36, MgSO4-7H2O 0.81, dextrose 5.55, KH2PO4
0.44, Na2HPO4-7H2O 0.34, and HEPES 20, pH 7.5]. Cells were ﬁxed
with 70% ethanol, pH 2, permeabilized with 0.05% Triton X-100 and in-
cubatedwith amouse anti-actin antibody. Cardiomyocyteswere identi-
ﬁed by primary antibody (anti-actin) and secondary antibody (APC).
Age matched WT and α1G−/−mice were studied on Day 1 (neonatal
mouse on day 1) (n = 12 for WT, n = 20 for α1G−/−, n: number of
the neonatal mouse hearts) or on Day 7 after birth (n = 28 for WT,
n = 20 for α1G−/−).
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mouse cardiomyocytes
Neonatal mice were given an intraperitoneal BrdU injection as
described previously. BrdU incorporation was measured using in-
structions within a BrdU intracellular staining kit (BD Pharmingen).
Cell cycle (DNA content) analysis was performed by staining DNA
with 7-amino actinomycin (7-AAD) (BD Pharmingen) using stan-
dard approaches. Flow cytometry data were analyzed using Diva
and FlowJo software.
2.8. Electrophysiology
L- (ICaL) and T-type (ICaT) Ca2+ currents were measured in a K-free
and Na-free solution [2]. Neonatal cardiomyocytes attached to cover
slips were placed in a chamber mounted on an inverted microscope
(Nikon Diaphot) and perfusedwith 1 mMCa2+ containing Tyrode solu-
tion. The temperature of inﬂowandoutﬂow solutionswasmaintained at
36 ± 1 °C. Pipetteswere ﬁlledwith a Cs-containing solution [N-methyl-
D-glucamine (NMDG) 10 mM, Cs-aspartate 130 mM, HEPES 10 mM,
MgCl2 1 mM, tetraethylammonium chloride 20 mM, Tris-ATP 2.5 mM
and EGTA 10 mM, pH 7.2] [2]. Once gigaseals were obtained the patch
was ruptured and the cell was dialyzed for 30 s. The extracellular
bath was then changed to one containing: CaCl2 2 mM, CsCl 5.4 mM,
4-aminopyridine 2 mM, MgCl2 1.2 mM, glucose 10 mM, HEPES 5 mM,
NMDG 150 mM and pH 7.4 with CsOH. An Axopatch 2B voltage-
clamp ampliﬁer was used to control the membrane potential and
membrane currents were analyzed with pClamp 8 software. Total cell
membrane T-type currents and L-type currents were measured from a
holding potential of−90 mV using square wave pulses from−70 mV
to +50 mV, in 10 mV increments. ICaL was measured from a holding
potential of −50 mV using identical square wave pulses. ICaT was
calculated by subtracting the ICaL measured from a holding potential
of −50 mV from the total Ca2+ current measured from a holing
potential of−90 mV.
2.9. Statistics
Data were expressed as mean ± SEM. Differences between WT,
α1G−/− and α1GDT were compared using unpaired Student's t-test.
For multiple repeat comparisons between WT, α1G−/− and α1GDT,
an ANOVA was performed. A p value of ≤0.05 was considered
signiﬁcant.
3. Results
3.1. T-type Ca2+ currents during the ﬁrst week of life and in adult mice
TTCC and LTCC currents were measured in neonatal myocytes 1 and
7 days after birth in WT and α1G−/− mice (Fig. 1). All myocytes
exhibited robust ICaL and there were no differences in ICaL density
between WT and α1G−/− myocytes at either day 1 or day 7 after
birth (Fig. 1). ICaT was only found in 35% of WT neonatal myocytes on
day 1 and we did not ﬁnd any WT myocytes with ICaT at day 7
(Figs. 1A, C). Signiﬁcantly fewer myocytes exhibited a measureable
ICaT in α1G−/−myocytes. On day 1 only 1 myocyte (4% of those stud-
ies) had a measureable ICaT. No ICaT was found at day 7 in the 27
α1G−/− myocytes studied. These results show that there is a
signiﬁcant loss of Ca2+ inﬂux through TTCC in WT myocytes and
α1G−/− myocytes have little or no Ca2+ entry via TTCCs during the
ﬁrst week of life. The ICaT found in the single α1G−/−myocyte at day
1 likely represents current through α1H TTCC, the other channel that
has been found in neonatal hearts [23,24]. These results also suggest
that the α1G TTCC is the major TTCC expressed in the neonatal
mouse heart during the ﬁrst week after birth and show that loss ofα1G does not induce a compensatory increase in the expression of
other TTCCs.
3.2. BrdU incorporation into WT and α1G−/− neonatal myocytes
Neonatal mice were injected with BrdU for 7 days and then BrdU+
myocyte nuclei were measured in the intact heart, with immuno-
staining (Fig. 2), or in isolated myocytes with ﬂow cytometry
(Fig. 3). Immunostaining of the intact heart showed a large number
of BrdU+ myocytes and non-myocytes. In WT 7 day old hearts,
20% of the myocyte nuclei were BrdU+with the BrdU labeling tech-
nique employed (Fig. 2). There were signiﬁcantly fewer BrdU+
myocyte nuclei (7%) in 7 day old α1G−/− hearts (Fig. 2).
Deﬁning myocyte speciﬁc nuclei in tissue sections can be chal-
lenging [21], so to conﬁrm the results of studies with tissue sections
we measured the % of BrdU+ myocyte nuclei in the experiments
with isolated myocytes using ﬂow cytometry (Fig. 3). These studies
also showed that there were signiﬁcantly more BrdU+ myocytes in
WT hearts (24%) than in α1G−/− (4%) hearts (Fig. 3). These two
independent techniques yielded very similar results and support the
conclusion that the % of 7 day old myocytes with BrdU+ nuclei was
signiﬁcantly smaller in α1G−/− hearts.
3.3. Cell cycle (DNA content) analysis with ﬂow cytometry
BrdU incorporation into myocyte DNA during the ﬁrst week of life
could represent myocyte proliferation or the doubling in myocyte
DNA content that takes place with binucleation, which has been asso-
ciated with exit from the cell cycle [25,26]. To examine these issues
we ﬁrst performed cell cycle (DNA content) analysis of neonatal
myocytes from WT and α1G−/− neonatal mouse hearts at days 1
and 7 after birth (Fig. 4). On Day 1 after birth more than 90% of all
myocytes from WT and α1G−/− hearts were in the G1/G0 phase of
the cell cycle with a 2N compliment of DNA. These results are consis-
tent with the idea that most neonatal myocytes were mononucleated
and newly formed, with some possibility that they are still capable of
cell cycle activity. Cell cycle (DNA content) analysis showed that
WT and α1G−/− myocytes made a 2N to 4N transition (Fig. 4) by
Day 7. However, signiﬁcantly fewer WT (52%) than α1G−/− (68%)
myocytes were still in the G1/G0 (2N) phase of the cell cycle on day
7 after birth, with more WT myocytes in the G2 (4N) phase. These
results show a 2N to 4N transition for cardiac myocytes in the ﬁrst
week after birth with a signiﬁcantly slower transition in α1G−/−
myocytes (Fig. 4). These changes in DNA content were closely associ-
ated with differences in nucleation (Fig. 5) and cell size (Fig. 6) be-
tween WT and α1G−/− myocytes during the ﬁrst week after birth
(see below).
3.4. Myocyte nucleation changes during the ﬁrst week of life
Myocytes were isolated from WT and α1G−/− hearts 1 and
7 days after birth to unambiguously determine the percentage of
mono and binucleated myocytes (Fig. 5). These studies provide a
third independent test of the changes in myocyte nucleation and
DNA content after birth. These experiments showed that the majority
(>95%) of WT and α1G−/− myocytes were mononucleated on Day
1 after birth (Fig. 5). By Day 7 the % of mononucleated myocytes
had fallen to 50% in theWT but only to 80% inα1Gmyocytes. Changes
in nucleation between and within both groups were signiﬁcant when
Day 1 versus Day 7 data were compared. In addition there was a
signiﬁcantly smaller reduction in the % of mononucleated myocytes
in α1G−/− versus WT myocytes during the ﬁrst week after birth.
The results of these three independent sets of experiments all support
the idea that in the absence of α1G TTCCs neonatal myocytes has a
slower 2N to 4N transition (mono- to bi-nucleation).
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Fig. 1. T- (ICaT) and L- (ICaL) type Ca2+ currents in neonatal mouse ventricular myocytes (NMVMs) 1 and 7 days after birth. (A) On day 1, ICaT was detected in 35% of WT myocytes,
and (B) in only 4% of α1G−/− NMVMs. On day 7, no ICaT was detected in WT (C) or (D) α1G−/−myocytes. ICaL was not different in either group at either 1 or 7 days after birth
(N: # of cells).
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the end the ﬁrst week of life (Fig. 6) in WT and α1G−/− myocytes.
The size of mononucleated and binucleated myocytes of 7 day old
WT myocytes was signiﬁcantly larger than in α1G−/− myocytes.WT-Day 7 
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Fig. 3. BrdU incorporation into DNA of NMVMs during the ﬁrst week after birth determined with ﬂow cytometry. NMVMs were isolated from BrdU injected mouse hearts 7 days after
birth. NRVMswere stained for cardiac actin-APC and BrdU-FITC to identifymyocytes within newly formed DNA. (A) Unstained control NRVMswere used to set thresholds for identifying
NRVMswith BrdU+DNA. This approachwas conﬁrmed versus studieswith animals that had not beenBrdU injected, butmyocyteswere stained for BrdU (see Supplemental Fig. 1). (B) In
wild type NMVMs 22.3% were BrdU+. (C) Inα1G−/− NMVMs 8.24% were BrdU+. (D) Average data from 10WT and 15α1G−/− NRVM preparations. There were signiﬁcantly more
BrdU+myocytes in WT versus α1G−/−myocytes. *p b 0.05 (N: # of hearts).
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from the cell cycle in neonatal myocytes.
3.5. T-type Ca2+ current, cell size and nucleation in the adult WT,
α1G and α1GDT hearts
We next explored if any of the differences in nucleation and
myocyte size observed in neonatal myocytes were still present in the
adult animal. These studies were performed at 2 months of age at a
time when we have shown that these hearts have normal (WT and
α1G−/−) or enhanced (α1GDT) [2] function and normal tissue struc-
ture with no ﬁbrosis [27]. We added the gain of function animals
(α1GDT) to the adult animal analyses to enhance the scope of the
work. These animals were not used in neonatal studies because
α1GDT expression was not activated until after birth. In addition,
there is modest α-MHC-mediated expression in the neonatal time
frame and our breeding strategy yielded only 25% DT animals.
Ca2+ currents were measured in adult WT and α1GDT myocytes
(Supplemental Fig. 2). ICaT was not found in any WT (or in α1G−/−,
not shown) adultmyocytes. Large ICaTwas observed inα1GDTmyocytes,
as we have reported previously [2].
We have previously reported that heart weight, normalized to
body weight or tibial length, is not different in 2 month old
α1G−/−,α1GDT andWTmice [27]. In the present study we isolated
myocytes from these hearts to measure myocyte size (surface area)
and myocyte nucleation (Figs. 7, 8). Measurements were made in
mono- and bi-nucleated myocytes from all three groups of mice.
Both mono- and bi-nucleated myocytes from α1G−/− hearts were
signiﬁcantly smaller than those from WT and α1GDT hearts.Bi-nucleated α1GDT myocytes were signiﬁcantly larger than those
from WT and α1G−/− hearts (Fig. 7).
Myocyte nucleation (mono- versus bi-nucleation)was alsomeasured
inmyocytes isolated fromWT,α1G−/− andα1GDT animals. More than
90% of all myocytes were binucleated inWT andα1GDT hearts. The % of
mononucleated myocytes was signiﬁcantly greater in α1G−/−
myocytes versus that of the other two groups (Fig. 8), consistent with
the results in the neonatal time period. Collectively these results suggest
that myocyte size and number are inﬂuenced by α1G TTCCs.
In summary, these experiments show that neonatal myocytes
without α1G TTCC are smaller than normal and appear to have a
slower than a normal exit from the cell cycle. The adult heart has
a normal size but has myocytes that are smaller than normal and
there is a greater percentage of mononucleated myocytes.4. Discussion
T-type Ca channels are expressed in cardiac myocytes in the fetal
and neonatal hearts [1], but are not normally found in adult ventricular
myocytes [8]. These channels are re-expressed in a subpopulation of
adult myocyte subjected to pathological stress [7,28]. The functional
role of TTCCs in ventricular myocytes is not well known. While TTCCs
allow voltage dependent Ca2+ current entry they are not involved
in the excitation–contraction coupling [2,29]. There is some data in
non-cardiac cell types showing that Ca2+ inﬂux through TTCCs is linked
to cell proliferation and to speciﬁc phases of the cell cycle [30,31,12,32].
In the present experiments we explored the association between TTCC
expression in the neonatal heart during the ﬁrst week after birth,
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Fig. 4. Representative DNA quantity analysis of isolated NMVMs using ﬂow cytometry. NMVMs were isolated on day 1 and day 7 after birth and then DNA content analysis was
performed. Single cells were gated. An antibody against cardiac actin was used to identify NMVMs. (A) wild type NMVMs on day 1. (B) α1G−/− NMVMs on day 1. (C) Wild
type NMVMs on day 7. (D) α1G−/− NMVMs on day 7. Increased DNA content was observed in NMVMs at 7 days after birth versus 1 day after birth (within groups). There
were more WT than α1G−/− myocytes with 4N DNA content. (E) There was no signiﬁcant difference in DNA content between wild type and α1G−/− on day 1 after birth.
(F) The percentage of NMVMs with 2N DNA content decreased in both WT and α1G−/−, however there were signiﬁcantly fewer α1G−/− NMVMs with 4N DNA content on
day 7 after birth. *p b 0.001 (N: # of hearts).
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from the cell cycle.
The major ﬁndings of this study are that 1) on Day 1 after birth
about 35% of ventricular myocytes had functional TTCCs, and this %
decreases during the ﬁrst week of life. 2a) by two months of age
normal ventricular myocytes do not have functional TTCCs; 2b)
α1G TTCCs appear to be the major TTCC expressed during the ﬁrstweek of life. 3) BrdU is incorporated into ventricular myocytes dur-
ing the ﬁrst week of life and this is associated with a 2N to 4N transi-
tion and binucleation, representing myocyte withdrawal from the
cell cycle. 4) Loss of α1G TTCCs was associated with a slower transi-
tion from mononucleation to binucleation and reduced BrdU incor-
poration in the ﬁrst week after birth; and 5) loss of α1G TTCC
resulted in an adult heart with more myocytes than are found in
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Fig. 5. Nucleation of NMVMs isolated on day 1 and day 7 after birth: (A) Almost all myocytes were mono-nucleated on Day 1 after birth in both α1G−/− andWTmice. (B) By day 7
after birth, a signiﬁcantly greater % WT NMVMs had become bi-nucleated than in α1G−/− myocytes. *p b 0.005, n: # of cells, N: # of hearts.
128 F. Wang et al. / Journal of Molecular and Cellular Cardiology 62 (2013) 122–130the WT heart and these myocytes are smaller and a greater % are
mononucleated. Collectively these data suggest that Ca2+ inﬂux
through α1G TTCCs regulates the transition from a proliferative
fetal myocyte to a terminally differentiated binucleated adult ven-
tricular myocyte during the ﬁrst week of neonatal life.
4.1. TTCCs and BrdU incorporation in myocytes in the ﬁrst week
after birth
Our studies show that 1 day after birth most of the myocytes in
the neonatal heart are mononucleated and a fraction (about 35%)
have functional TTCCs and almost all myocytes are mononucleated.
By Day 7 after birth very few myocytes express TTCCs and many ofC
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on day 7. Cardiac actin is in red and DAPI is in blue.α1G−/−NMVMswere signiﬁcantly smalle
in α1G−/− (n = 115). (D) Cell surface area of WT bi-nucleated NMVMs was greater (n = 5the myocytes have become binucleated, which we interpret as a
sign that they have withdrawn from the cell cycle [26,33]. When
BrdU was infused during the ﬁrst week of life about 25% of the
myocytes were labeled. Our interpretation of all of these data is that
the primary form of DNA synthesis during the ﬁrst week of life is
associated with a 2N to 4N transition (which we document) and
this is associated with a loss of TTCC activity. Support for a cause
and effect relationship between TTCCs and these changes in myocyte
nucleation was gained from experiments with α1G−/− animals.
These experiments showed that like WT myocytes, most α1G−/−
myocytes were mononucleated on Day 1 after birth, but a very
small fraction of myocytes expressed TTCC currents. Presumably
these myocytes expressed the α1H TTCC [1,34]. On Day 7 after birthB
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Fig. 7. Nucleation analysis of 2 months old WT, α1G−/− and α1GDT myocytes. The
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129F. Wang et al. / Journal of Molecular and Cellular Cardiology 62 (2013) 122–130we failed to ﬁnd any α1G−/− myocytes with TTCC currents. We
showed that during the ﬁrst week of neonatal life, fewer α1G−/−
myocytes made the 2N to 4N transition, less were binucleated and a
smaller % were labeled with BrdU. Myocytes from these α1G−/−
hearts were smaller than WT myocytes at 7 days after birth. These
results are consistent with the idea that Ca2+ inﬂux through TTCCs
regulates myocyte growth, the 2N to 4N (binucleation) transition
and the associated exit of cardiac myocytes from the cell cycle. If true
this would suggest that α1G−/− hearts have a longer than a normal
time period during which their ventricular myocytes can proliferate.
4.2. TTCCs, myocyte number and myocyte nucleation in the adult heart
Heart size is not signiﬁcantly altered by either the gain or loss of
α1G TTCCs, in spite of the fact that the α1GDT mice have a modest
hypercontractile phenotype [18]. The fact that α1G−/− myocytes
are smaller, and α1GDT myocytes are larger than WT suggests that
TTCCs inﬂuence myocyte growth. This is clearly a complicated issueC
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Fig. 8. Cell surface area was measured in myocytes isolated from wild type (N = 3), α
mono-nucleated myocytes in wild type (n = 55) and in α1GDT (n = 66) was larger tha
type (n = 630) and α1GDT (n = 503) hearts were larger than in α1G−/− (n = 539). (C
shown. Cardiac α-actin is in red and DAPI is in blue. *p b 0.0001, n: # of myocytes, N: # ofsince in pathological stress α1GDT hearts have less hypertrophy
while α1G−/− have more hypertrophy [27]. α1G−/− myocytes
also had a signiﬁcantly higher fraction of mononucleated myocytes.
These data suggest that the number and nucleation pattern of myocytes
within the adult heart are inﬂuenced by the absence or presence of
TTCCs. We speculate that neonatal α1G−/− myocytes could retain a
low level of proliferative activity resulting in the increased number of
small myocytes which we found in the adult heart, while α1GDT
myocytes might exit from the cell cycle at a faster than a normal rate,
resulting in fewer, larger myocytes in the adult heart. These issues can-
not be resolvedwith the studies performed here and deserve additional
study. Importantly there is no evidence for cardiac ﬁbrosis or any path-
ological phenotypes in any of themousemodels used in this study [27].
The presence of normal cardiac histology allows us to approximate
the relative myocyte number in each of these three mouse groups,
as we have done in previous studies [35]. Our ﬁndings suggest that
α1G−/− hearts have the greatest number of myocytes (per unit
mass) while α1GDT hearts have the smallest number of myocytes.
The major ﬁndings of this study are all consistent with the idea
that Ca2+ inﬂux through TTCCs regulates myocyte growth as well as
the transition from mono- to bi-nucleation and the associated exit
of myocytes from the cell cycle soon after birth. α1G−/− myocytes
appear to have a reduced rate of cell cycle withdrawal, resulting in
an adult heart with a normal size but with an increased number of
small, mononucleated myocytes. α1GDT myocytes are larger than
normal, yet their hearts are also normal in size. This is a complex phe-
notype that could result from a premature exit of myocytes from the
cell cycle, resulting in a reduced number of myocytes per unit mass.
The α1GDT phenotype is more complicated because these myocytes
(and hearts) are hypercontractile [27] and this could induce second-
ary reactive phenotypic features.
There are a number of limitations in our study that largely result
from the fact that it is challenging to study cell cycle activity in the
heart and to determine the source of new cardiac myocytes. OurD
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130 F. Wang et al. / Journal of Molecular and Cellular Cardiology 62 (2013) 122–130results are consistent with the idea that there may be a greater num-
ber of smaller, mononucleated myocytes in the α1G−/− adult heart.
It is unclear if the basis for this is enhanced myocyte proliferation and
if this occurs during fetal life or during the maturation of the adult
heart. How α1G TTCCs are linked to the alterations in myocyte size,
nucleation and the capacity for proliferative activity is, in our view,
an issue deserving study.
In summary, these experiments suggest that TTCCs are expressed
transiently in cardiac myocytes and the resultant Ca2+ inﬂux is in-
volved in the regulation of myocyte growth and the exit of neonatal
myocytes from the cell cycle. Understanding the molecular bases of
these processes could lead to novel strategies to coax myocytes into
or out of the cell cycle to generate new cardiac myocytes in times
of stress.
Appendix A. Supplementary data
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.yjmcc.2013.05.016.
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